学会発表（国際）
Superior efficacy of anastrozole to tamoxifen as adjuvant therapy for postmenopausal patients with hormone-responsive breast cancer. Efficacy results of long-term follow-up data from N-SAS BC 03 trial.
Imoto S, Osumi S, Aogi K, Hozumi Y, Mukai H, Iwata H, Yokota I, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Aihara T. Superior efficacy of anastrozole to tamoxifen as adjuvant therapy for postmenopausal patients with hormone-responsive breast cancer. Efficacy results of long-term follow-up data from N-SAS BC 03 trial. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 6, 2012. Abstract 850927.